Ensysce Biosciences Probability of Future Pink Sheet Price Finishing Over 0.009

ENSCWDelisted Stock  USD 0.01  0.0008  8.16%   
Ensysce Biosciences' future price is the expected price of Ensysce Biosciences instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Ensysce Biosciences performance during a given time horizon utilizing its historical volatility. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
  
Please specify Ensysce Biosciences' target price for which you would like Ensysce Biosciences odds to be computed.

Ensysce Biosciences Target Price Odds to finish over 0.009

The tendency of Ensysce Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.01 90 days 0.01 
about 86.11
Based on a normal probability distribution, the odds of Ensysce Biosciences to move above the current price in 90 days from now is about 86.11 (This Ensysce Biosciences probability density function shows the probability of Ensysce Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Ensysce Biosciences has a beta of -10.21 suggesting as returns on its benchmark rise, returns on holding Ensysce Biosciences are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Ensysce Biosciences is expected to outperform its benchmark. In addition to that Ensysce Biosciences has an alpha of 9.1877, implying that it can generate a 9.19 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Ensysce Biosciences Price Density   
       Price  

Predictive Modules for Ensysce Biosciences

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ensysce Biosciences. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ensysce Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.010.010.01
Details
Intrinsic
Valuation
LowRealHigh
0.010.010.01
Details

Ensysce Biosciences Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Ensysce Biosciences is not an exception. The market had few large corrections towards the Ensysce Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Ensysce Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Ensysce Biosciences within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
9.19
β
Beta against Dow Jones-10.21
σ
Overall volatility
0.01
Ir
Information ratio 0.13

Ensysce Biosciences Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ensysce Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ensysce Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Ensysce Biosciences is not yet fully synchronised with the market data
Ensysce Biosciences has some characteristics of a very speculative penny stock
Ensysce Biosciences has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (29.15 M) with profit before overhead, payroll, taxes, and interest of 0.
Ensysce Biosciences generates negative cash flow from operations
Latest headline from thelincolnianonline.com: NRx Pharmaceuticals, Inc. Sees Large Increase in Short Interest

Ensysce Biosciences Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Ensysce Pink Sheet often depends not only on the future outlook of the current and potential Ensysce Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ensysce Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding1.2 M
Cash And Short Term Investments12.3 M

Ensysce Biosciences Technical Analysis

Ensysce Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Ensysce Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Ensysce Biosciences. In general, you should focus on analyzing Ensysce Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

Ensysce Biosciences Predictive Forecast Models

Ensysce Biosciences' time-series forecasting models is one of many Ensysce Biosciences' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Ensysce Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about Ensysce Biosciences

Checking the ongoing alerts about Ensysce Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Ensysce Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Ensysce Biosciences is not yet fully synchronised with the market data
Ensysce Biosciences has some characteristics of a very speculative penny stock
Ensysce Biosciences has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (29.15 M) with profit before overhead, payroll, taxes, and interest of 0.
Ensysce Biosciences generates negative cash flow from operations
Latest headline from thelincolnianonline.com: NRx Pharmaceuticals, Inc. Sees Large Increase in Short Interest
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Consideration for investing in Ensysce Pink Sheet

If you are still planning to invest in Ensysce Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ensysce Biosciences' history and understand the potential risks before investing.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings